Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-SARS-CoV-2 antibody kinetics up to 6 months of follow-up: Result from a nation-wide population-based, age stratified sero-epidemiological prospective cohort study in India.
Misra P, Singh AK, Mishra B, Behera B, Patro BK, Medigeshi GR, Joshi HS, Ahmad M, Chaturvedi PK, Chinnakali P, Haldar P, Bairwa M, Kharya P, Dhodapkar R, Rath R, Guleria R, Rai SK, Kar SS, Kant S, Sarkar S, Baidya S, Meena S, Mandal S, Kishore S, Majumder T, Hada V. Misra P, et al. Among authors: guleria r. PLoS One. 2023 Dec 11;18(12):e0287807. doi: 10.1371/journal.pone.0287807. eCollection 2023. PLoS One. 2023. PMID: 38079384 Free PMC article.
Cell-Mediated Immunity (CMI) for SARS-CoV-2 Infection Among the General Population of North India: A Cross-Sectional Analysis From a Sub-sample of a Large Sero-Epidemiological Study.
Misra P, Garg PK, Awasthi A, Kant S, Rai SK, Ahmad M, Guleria R, Deori TJ, Mandal S, Jaiswal A, Gongal G, Vishwakarma S, Bairwa M, Kumar R, Haldar P, Binayke A. Misra P, et al. Among authors: guleria r. Cureus. 2023 Nov 15;15(11):e48824. doi: 10.7759/cureus.48824. eCollection 2023 Nov. Cureus. 2023. PMID: 38106811 Free PMC article.
Long-Term Kinetics of SARS-CoV-2 Neutralizing and Anti-Receptor Binding Domain Antibodies among Laboratory-Confirmed COVID-19 Cases in Delhi National Capital Region, India: A Prospective, One-Year Follow-Up Study.
Misra P, Medigeshi GR, Kant S, Jaiswal A, Ahmad M, Rahman A, Guleria R, Rai SK, Deori TJ, Mandal S, Gongal G, Bairwa M, Haldar P, Kumar R, Garg N. Misra P, et al. Among authors: guleria r. J Clin Med. 2024 Jan 29;13(3):762. doi: 10.3390/jcm13030762. J Clin Med. 2024. PMID: 38337457 Free PMC article.
The Effectiveness of SARS-CoV-2 Vaccination in Preventing Severe Illness and Death - Real-world Data from a Cohort of Patients Hospitalized with COVID-19.
Sagiraju HKR, Elavarasi A, Gupta N, Garg RK, Paul SS, Vig S, Sirohiya P, Ratre B, Garg R, Pandit A, Singh R, Kumar B, Meena VP, Wig N, Mittal S, Pahuja S, Madan K, Das N, Dwivedi T, Gupta R, Wundavalli L, Singh AR, Singh S, Mishra A, Pandey M, Matharoo KS, Kumar S, Mohan A, Guleria R, Bhatnagar S. Sagiraju HKR, et al. Among authors: guleria r. Indian J Community Med. 2022 Oct-Dec;47(4):510-516. doi: 10.4103/ijcm.ijcm_1388_21. Epub 2022 Dec 14. Indian J Community Med. 2022. PMID: 36742977 Free PMC article.
Phylogeny and evolution of SARS-CoV-2 during Delta and Omicron variant waves in India.
Singh UB, Deb S, Rani L, Gupta R, Verma S, Kumari L, Bhardwaj D, Bala K, Ahmed J, Gaurav S, Perumalla S, Nizam M, Mishra A, Stephenraj J, Shukla J, Nayer J, Aggarwal P, Kabra M, Ahuja V, Chaudhry R, Sinha S, Guleria R. Singh UB, et al. Among authors: guleria r. J Biomol Struct Dyn. 2024 Jun;42(9):4769-4781. doi: 10.1080/07391102.2023.2222832. Epub 2023 Jun 15. J Biomol Struct Dyn. 2024. PMID: 37318006
Genomic surveillance of SARS-CoV-2 upsurge in India due to Omicron sub-lineages BA.2.74, BA.2.75 and BA.2.76.
Singh UB, Deb S, Rani L, Bhardwaj D, Gupta R, Kabra M, Bala K, Kumari L, Perumalla S, Shukla J, Nayer J, Aggarwal P, Ahuja V, Chaudhry R, Sinha S, Guleria R. Singh UB, et al. Among authors: guleria r. Lancet Reg Health Southeast Asia. 2023 Apr;11:100148. doi: 10.1016/j.lansea.2023.100148. Epub 2023 Jan 11. Lancet Reg Health Southeast Asia. 2023. PMID: 36643851 Free PMC article. No abstract available.
A multicentre, double-blind, placebo-controlled randomized trial of Mycobacterium w in critically ill patients with COVID-19 (ARMY-2).
Sehgal IS, Agarwal R, Jindal A, Siddiqui MS, Mohan A, Pal A, Guleria R, Bhalla A, Kajal K, Malhotra P, Puri GD, Khadanga S, Joshi R, Singh S, Saigal S, Nagarkar NM, Suri V, Bhatnagar S, Tiwari P, Singh MP, Yaddanapudi LN, Mittal S, Chauhan A, Banerjee G, Rai DK, Gupta BK; ARMY-2 trial study group*. Sehgal IS, et al. Among authors: guleria r. Lung India. 2024 Mar 1;41(2):84-92. doi: 10.4103/lungindia.lungindia_426_23. Epub 2024 Feb 27. Lung India. 2024. PMID: 38700400 Free PMC article.
Clinicoepidemiological Features and Mortality Analysis of Deceased Patients with COVID-19 in a Tertiary Care Center.
Aggarwal R, Bhatia R, Kulshrestha K, Soni KD, Viswanath R, Singh AK, Iyer KV, Khanna P, Bhattacharjee S, Patel N, Aravindan A, Gupta A, Singh Y, Ganesh V, Kumar R, Ayub A, Kumar S, Prakash K, Venkateswaran V, Bhoi D, Soneja M, Mathur P, Malhotra R, Wig N, Guleria R, Trikha A. Aggarwal R, et al. Among authors: guleria r. Indian J Crit Care Med. 2021 Jun;25(6):622-628. doi: 10.5005/jp-journals-10071-23848. Indian J Crit Care Med. 2021. PMID: 34316140 Free PMC article.
510 results